{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21974805",
  "DateCompleted": {
    "Year": "2012",
    "Month": "01",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2011",
        "Month": "09",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.canlet.2011.09.003"
    ],
    "Journal": {
      "ISSN": "1872-7980",
      "JournalIssue": {
        "Volume": "313",
        "Issue": "2",
        "PubDate": {
          "Year": "2011",
          "Month": "Dec",
          "Day": "27"
        }
      },
      "Title": "Cancer letters",
      "ISOAbbreviation": "Cancer Lett"
    },
    "ArticleTitle": "Galectin-3--a jack-of-all-trades in cancer.",
    "Pagination": {
      "StartPage": "123",
      "EndPage": "128",
      "MedlinePgn": "123-8"
    },
    "Abstract": {
      "AbstractText": [
        "Galectin-3 is a mammalian \u03b2-galactoside-binding protein that is expressed by various types of human cells. Changes in galectin-3 expression and subcellular and intercellular localizations are commonly seen in cancer and pre-cancerous conditions. It is increasingly recognized that galectin-3 is an important regulator of a broad range of cancer cell activities and plays important roles in cancer cell growth, transformation, apoptosis, angiogenesis, adhesion, invasion and metastasis. Such a divergent influence of galectin-3 on cancer cell activities derives from its multiple inter- and sub-cellular localizations where it interacts with a range of different binding partners. This mini-review summaries the diverse influences of galectin-3 on cancer cell behaviours with particular emphasis on its role in tumorigenesis and metastasis."
      ],
      "CopyrightInformation": "Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3GE, UK."
          }
        ],
        "LastName": "Newlaczyl",
        "ForeName": "Anna U",
        "Initials": "AU"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yu",
        "ForeName": "Lu-Gang",
        "Initials": "LG"
      }
    ],
    "GrantList": [
      {
        "GrantID": "C7596",
        "Agency": "Cancer Research UK",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Ireland",
    "MedlineTA": "Cancer Lett",
    "NlmUniqueID": "7600053",
    "ISSNLinking": "0304-3835"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Galectin 3"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Cell Adhesion"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Galectin 3"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Invasiveness"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Metastasis"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Neovascularization, Pathologic"
    }
  ]
}